On diabetic foot, wound healing, amputation prevention, and the merger of consumer tech with medical devices
Click above for superb data from Rooney and coworkers. OBJECTIVE To estimate the global, regional, and national prevalence of prediabetes, defined by impaired glucose tolerance (IGT) or impaired fasting glucose (IFG). RESEARCH DESIGN AND METHODS We reviewed 7,014 publications for high-quality estimates of IGT (2-h glucose, 7.8–11.0 mmol/L [140–199 mg/dL]) and IFG (fasting glucose, 6.1–6.9... Continue Reading →
Important work from Andersen and coworkers on a potentially reproducible, minimally invasive clinical procedure to reduce pressure on distal digits with flexible deformities. Objective: The aim of this study was to evaluate the effects of needle flexor tendon tenotomy treatment of the diabetic hammertoe deformity. Research design and methods: A multicenter randomized controlled trial of individuals with... Continue Reading →
The At-Risk Diabetic Foot: Time to Focus on Prevention Just published in the journal Diabetes Care by our combined team including Bob Frykberg, Loretta Vileikyte, Andrew Boulton and me
Important work from Jeffcoate and Game in Diabetes Care continues the slow, steady march toward measuring, managing, and understanding what I like to call an enigma wrapped in edema. The Charcot Foot Reflects a Response to Injury That Is Critically Distorted by Preexisting Nerve Damage: An Imperfect Storm William Jeffcoate and Fran Game It has... Continue Reading →
This from our @UofA / @BCM, UTSouthwestern and Oklahoma SALSA team. 6.7 million diabetic foot ulcers, 785 million diabetes-related outpatient visits and 5.5 billion visits overall suggest that diabetic foot ulcers are common, complex, and costly. Compare this frequently silent and sinister problem to CHF, MI, stroke. OBJECTIVE: To evaluate ambulatory clinical cases of diabetic foot... Continue Reading →
